Bath & Body Works' Q1 sales fall less than expected, adjusted EPS beats
Bath & Body Works, Inc. BBWI | 0.00 |
Overview
U.S. personal care retailer's Q1 net sales fell 3% but beat analyst expectations
Adjusted EPS for Q1 was $0.32, beating analyst expectations
CFO Eva Boratto to step down June 12; interim CFO appointed
Outlook
Bath & Body Works maintains 2026 net sales guidance of down 4.5% to down 2.5%
Company expects 2026 adj EPS of $2.40 to $2.65
Bath & Body Works forecasts Q2 net sales to decline 5% to 3%
Result Drivers
CORE CATEGORY INITIATIVES - Co said efforts to strengthen hero categories, modernize the brand, and expand reach are beginning to resonate with consumers, per CEO Daniel Heaf
SALES DECLINE - Q1 net sales fell 3%, with U.S. and Canada store sales down 4.3% and direct sales down 1.5%, partially offset by 9% growth in international and other sales
Company press release: ID:nGNX71Rbbh
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Sales |
Beat |
$1.38 bln |
$1.36 bln (15 Analysts) |
Q1 Adjusted EPS |
Beat |
$0.32 |
$0.29 (15 Analysts) |
Q1 EPS |
|
$0.90 |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 13 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy."
Wall Street's median 12-month price target for Bath & Body Works Inc is $25.00, about 41% above its May 26 closing price of $17.73
The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 8 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
